Search Results - Himal Chapagain
- Showing 1 - 2 results of 2
-
1
Omics and Extreme Phenotyping Reveal Longitudinal Association Between Left Atrial Size and Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension by Neil J. Kelly, David Newhouse, Himal Chapagain, Ashish Patel, Yicheng Tang, Ato Howard, Anna Kirillova, Hee‐Jung J. Kim, Haris Rahman, Wadih El Khoury, Seyed Mehdi Nouraie, Gavin Hickey, Leyla Elif Sade, Sandeep Jain, Stephen Y. Chan
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2023-12-01)Get full text
Article -
2
Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD by Jonathan Arnold, Deeksha Acharya, Hetal Boricha, Himal Chapagain, Aleesha Kainat, Allison Bradley, Jong-Hyeon Jeong, Kevin A. Townsend, Mohammad B. Ateya, David A. DeMicco, Yousef Alish, Michael J. Becich, Cynthia H. Chuang, Soledad A. Fernandez, Daniel E. Ford, Wenke Hwang, H. Lester Kirchner, Richard Morgan, Anuradha Paranjape, Neena A. Thomas, David A. Williams, Rozelle Hegeman-Dingle, Euan McLeod, Phillip A. Saccone, Kathleen M. McTigue
Published in American Journal of Preventive Cardiology (2025-09-01)Get full text
Article